ROS-dependent prostate apoptosis response-4 (Par-4) up-regulation and ceramide generation are the prime signaling events associated with curcumin-induced autophagic cell death in human malignant glioma

Faisal Thayyullathil, Anees Rahman, Siraj Pallichankandy, Mahendra Patel, Sehamuddin Galadari

    Research output: Contribution to journalArticle

    Abstract

    Malignant gliomas are extremely resistant to therapies that induce apoptosis, but are less resistant to therapies that induce autophagy. Therefore, drugs targeting autophagy are promising in the management of malignant gliomas. In this study, we investigated the anti-glioma potential of curcumin in vitro, and further examined the molecular mechanisms of curcumin-induced cell death in human malignant glioma. Here, we provide evidence that curcumin is cytotoxic against human malignant glioma cell lines, and the mechanism of cell death caused by curcumin is associated with features of autophagy. Curcumin suppresses the growth of human malignant glioma cells via ROS-dependent prostate apoptosis response-4 (Par-4) induction and ceramide generation. Extracellular supplementation of antioxidants such as glutathione and N-acetylcysteine to glioma cells abrogated the Par-4 induction, ceramide generation, and in turn, prevented curcumin-induced autophagic cell death. Moreover, tumor cells transfected with Par-4 gene sensitized the curcumin-induced autophagic cell death. Overall, this study describes a novel signaling pathway by which curcumin induces ROS-dependent Par-4 activation and ceramide generation, leading to autophagic cell death in human malignant glioma cells.

    Original languageEnglish (US)
    Pages (from-to)763-776
    Number of pages14
    JournalFEBS Open Bio
    Volume4
    DOIs
    StatePublished - Dec 1 2014

    Fingerprint

    Curcumin
    Ceramides
    Autophagy
    Cell death
    Glioma
    Prostate
    Up-Regulation
    Apoptosis
    Cell Death
    Cells
    Acetylcysteine
    Drug Delivery Systems
    Glutathione
    Tumors
    Antioxidants
    Genes
    Chemical activation
    Cell Line
    Therapeutics
    Growth

    Keywords

    • Autophagy
    • Ceramide
    • Curcumin
    • Glioma
    • Par-4
    • ROS

    ASJC Scopus subject areas

    • Biochemistry, Genetics and Molecular Biology(all)

    Cite this

    ROS-dependent prostate apoptosis response-4 (Par-4) up-regulation and ceramide generation are the prime signaling events associated with curcumin-induced autophagic cell death in human malignant glioma. / Thayyullathil, Faisal; Rahman, Anees; Pallichankandy, Siraj; Patel, Mahendra; Galadari, Sehamuddin.

    In: FEBS Open Bio, Vol. 4, 01.12.2014, p. 763-776.

    Research output: Contribution to journalArticle

    @article{6bbd890721c84b84ad360636a43b006e,
    title = "ROS-dependent prostate apoptosis response-4 (Par-4) up-regulation and ceramide generation are the prime signaling events associated with curcumin-induced autophagic cell death in human malignant glioma",
    abstract = "Malignant gliomas are extremely resistant to therapies that induce apoptosis, but are less resistant to therapies that induce autophagy. Therefore, drugs targeting autophagy are promising in the management of malignant gliomas. In this study, we investigated the anti-glioma potential of curcumin in vitro, and further examined the molecular mechanisms of curcumin-induced cell death in human malignant glioma. Here, we provide evidence that curcumin is cytotoxic against human malignant glioma cell lines, and the mechanism of cell death caused by curcumin is associated with features of autophagy. Curcumin suppresses the growth of human malignant glioma cells via ROS-dependent prostate apoptosis response-4 (Par-4) induction and ceramide generation. Extracellular supplementation of antioxidants such as glutathione and N-acetylcysteine to glioma cells abrogated the Par-4 induction, ceramide generation, and in turn, prevented curcumin-induced autophagic cell death. Moreover, tumor cells transfected with Par-4 gene sensitized the curcumin-induced autophagic cell death. Overall, this study describes a novel signaling pathway by which curcumin induces ROS-dependent Par-4 activation and ceramide generation, leading to autophagic cell death in human malignant glioma cells.",
    keywords = "Autophagy, Ceramide, Curcumin, Glioma, Par-4, ROS",
    author = "Faisal Thayyullathil and Anees Rahman and Siraj Pallichankandy and Mahendra Patel and Sehamuddin Galadari",
    year = "2014",
    month = "12",
    day = "1",
    doi = "10.1016/j.fob.2014.08.005",
    language = "English (US)",
    volume = "4",
    pages = "763--776",
    journal = "FEBS Open Bio",
    issn = "2211-5463",
    publisher = "Elsevier BV",

    }

    TY - JOUR

    T1 - ROS-dependent prostate apoptosis response-4 (Par-4) up-regulation and ceramide generation are the prime signaling events associated with curcumin-induced autophagic cell death in human malignant glioma

    AU - Thayyullathil, Faisal

    AU - Rahman, Anees

    AU - Pallichankandy, Siraj

    AU - Patel, Mahendra

    AU - Galadari, Sehamuddin

    PY - 2014/12/1

    Y1 - 2014/12/1

    N2 - Malignant gliomas are extremely resistant to therapies that induce apoptosis, but are less resistant to therapies that induce autophagy. Therefore, drugs targeting autophagy are promising in the management of malignant gliomas. In this study, we investigated the anti-glioma potential of curcumin in vitro, and further examined the molecular mechanisms of curcumin-induced cell death in human malignant glioma. Here, we provide evidence that curcumin is cytotoxic against human malignant glioma cell lines, and the mechanism of cell death caused by curcumin is associated with features of autophagy. Curcumin suppresses the growth of human malignant glioma cells via ROS-dependent prostate apoptosis response-4 (Par-4) induction and ceramide generation. Extracellular supplementation of antioxidants such as glutathione and N-acetylcysteine to glioma cells abrogated the Par-4 induction, ceramide generation, and in turn, prevented curcumin-induced autophagic cell death. Moreover, tumor cells transfected with Par-4 gene sensitized the curcumin-induced autophagic cell death. Overall, this study describes a novel signaling pathway by which curcumin induces ROS-dependent Par-4 activation and ceramide generation, leading to autophagic cell death in human malignant glioma cells.

    AB - Malignant gliomas are extremely resistant to therapies that induce apoptosis, but are less resistant to therapies that induce autophagy. Therefore, drugs targeting autophagy are promising in the management of malignant gliomas. In this study, we investigated the anti-glioma potential of curcumin in vitro, and further examined the molecular mechanisms of curcumin-induced cell death in human malignant glioma. Here, we provide evidence that curcumin is cytotoxic against human malignant glioma cell lines, and the mechanism of cell death caused by curcumin is associated with features of autophagy. Curcumin suppresses the growth of human malignant glioma cells via ROS-dependent prostate apoptosis response-4 (Par-4) induction and ceramide generation. Extracellular supplementation of antioxidants such as glutathione and N-acetylcysteine to glioma cells abrogated the Par-4 induction, ceramide generation, and in turn, prevented curcumin-induced autophagic cell death. Moreover, tumor cells transfected with Par-4 gene sensitized the curcumin-induced autophagic cell death. Overall, this study describes a novel signaling pathway by which curcumin induces ROS-dependent Par-4 activation and ceramide generation, leading to autophagic cell death in human malignant glioma cells.

    KW - Autophagy

    KW - Ceramide

    KW - Curcumin

    KW - Glioma

    KW - Par-4

    KW - ROS

    UR - http://www.scopus.com/inward/record.url?scp=84949117662&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84949117662&partnerID=8YFLogxK

    U2 - 10.1016/j.fob.2014.08.005

    DO - 10.1016/j.fob.2014.08.005

    M3 - Article

    VL - 4

    SP - 763

    EP - 776

    JO - FEBS Open Bio

    JF - FEBS Open Bio

    SN - 2211-5463

    ER -